Clinical Trial Update: Study of Platinum Plus Etoposide With or Without Tislelizumab in Participants With Untreated Extensive-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating platinum plus etoposide with or without tislelizumab in untreated extensive-stage small cell lung cancer has completed and posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: BeiGene | Conditions: Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2025-02-28